Smad signaling in the rat model of monocrotaline pulmonary hypertension

Toxicologic Pathology

Volumn 36, Issue 2, 2008, Pages 311-320

  Ramos, Margaret F ^a,d   Lamé, Michael W ^b   Segall, Henry J ^b   Wilson, Dennis W ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d ALLERGAN INC   (United States)

Author keywords

BMP receptors; Monocrotaline; Pulmonary hypertension; Smad signal transduction

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; MONOCROTALINE; SMAD PROTEIN; SMAD1 PROTEIN; SMAD2 PROTEIN; SMAD4 PROTEIN; SODIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; ENDOTHELIUM CELL; GENE EXPRESSION; GENE LOCATION; GENETIC ASSOCIATION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PULMONARY HYPERTENSION; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ACTIVIN RECEPTORS; ANIMALS; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; BONE MORPHOGENETIC PROTEINS; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; HYPERTENSION, PULMONARY; INJECTIONS, INTRAPERITONEAL; LUNG; MALE; MONOCROTALINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SMAD1 PROTEIN; SMAD2 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA; RATTUS;

EID: 42149122684     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623307311402     Document Type: Article

References (51)

1. Arcot, S.S., Lipke, D.W., Gillespie, M.N., and Olson, J.W. (1993). Alterations of growth factor transcripts in rat lungs during development of monocrotaline-induced pulmonary hypertension. Biochem Pharmacol 46, 1086-91.
2. Atkinson, C., Stewart, S., Upton, P.D., Machado, R., Thomson, J.R., Trembath, R.C., and Morrell, N.W. (2002). Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor. Circulation 105, 1672-8.
3. Chen, Y.G., and Massague, J. (1999). Smad1 recognition and activation by the ALK1 group of transforming growth factor-beta family receptors. J Biol Chem 274, 3672-7.
4. Deng, Z., Morse, J.H., Slager, S.L., Cuervo, N., Moore, K.J., Venetos, G., Kalachikov, S., Cayanis, E., Fischer, S.G., Barst, R.J., Hodge, S.E., and Knowles, J.A. (2000). Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet 67, 737-44.
5. Derynck, R., and Zhang, Y.E. (2003). Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425, 577-84.
6. Foletta, V.C., Lim, M.A., Soosairajah, J., Kelly, A.P., Stanley, E.G., Shannon, M., He, W., Das, S., Massague, J., and Bernard, O. (2003). Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1. J Cell Biol 162, 1089-98.
7. Geraci, M.W., Moore, M., Gesell, T., Yeager, M.E., Alger, L., Golpon, H., Gao, B., Loyd, J.E., Tuder, R.M., and Voelkel, N.F. (2001). Gene expression patterns in the lungs of patients with primary pulmonary hypertension: a gene microarray analysis. Circ Res 88, 555-62.
8. Ghodsi, F., and Will, J.A. (1981). Changes in pulmonary structure and function induced by monocrotaline intoxication. Am J Physiol 240, H149-55.
9. Goumans, M.J., Lebrin, F., and Valdimarsdottir, G. (2003). Controlling the angiogenic switch: a balance between two distinct TGF-β receptor signaling pathways. Trends Cardiovasc Med 13, 301-7.
10. Goumans, M.J., Valdimarsdottir, G., Itoh, S., Rosendahl, A., Sideras, P., and ten Dijke, P. (2002). Balancing the activation state of the endothelium via two distinct TGF-β type I receptors. Embo J 21, 1743-53.
11. Gullick, W.J., Downward, J., and Waterfield, M.D. (1985). Antibodies to the autophosphorylation sites of the epidermal growth factor receptor protein-tyrosine kinase as probes of structure and function. Embo J 4, 2869-77.
12. He, W., Li, A.G., Wang, D., Han, S., Zheng, B., Goumans, M.J., Ten Dijke, P., and Wang, X.J. (2002). Overexpression of Smad7 results in severe pathological alterations in multiple epithelial tissues. Embo J 21, 2580-90.
13. Inman, G.J., Nicolas, F.J., and Hill, C.S. (2002). Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-beta receptor activity. Mol Cell 10, 283-94.
14. Ishikawa, T., Yoshioka, H., Ohuchi, H., Noji, S., and Nohno, T. (1995). Truncated type II receptor for BMP-4 induces secondary axial structures in Xenopus embryos. Biochem Biophys Res Commun 216, 26-33.
15. Javois, L. C., ed. (1994). Immunocytochemical Methods and Protocols. Humana Press, Inc., Totowa, NJ.
16. Lame, M.W., Jones, A.D., Wilson, D.W., Dunston, S.K., and Segall, H.J. (2000). Protein targets of monocrotaline pyrrole in pulmonary artery endothelial cells. J Biol Chem 275, 29091-9.
17. Lame, M.W., Jones, A.D., Wilson, D.W., and Segall, H.J. (2005). Monocrotaline pyrrole targets proteins with and without cysteine residues in the cytosol and membranes of human pulmonary artery endothelial cells. Proteomics 5, 4398-413.
18. Lane, K.B., Machado, R.D., Pauciulo, M.W., Thomson, J.R., Phillips, J.A., 3rd, Loyd, J.E., Nichols, W.C., and Trembath, R.C. (2000). Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. The International PPH Consortium. Nat Genet 26, 81-4.
19. Lebrin, F., Deckers, M., Bertolino, P., and Ten Dijke, P. (2005). TGF-beta receptor function in the endothelium. Cardiovasc Res 65, 599-608.
20. Machado, R.D., Aldred, M.A., James, V., Harrison, R.E., Patel, B., Schwalbe, E.C., Gruenig, E., Janssen, B., Koehler, R., Seeger, W., Eickelberg, O., Olschewski, H., Elliott, C.G., Glissmeyer, E., Carlquist, J., Kim, M., Torbicki, A., Fijalkowska, A., Szewczyk, G., Parma, J., Abramowicz, M.J., Galie, N., Morisaki, H., Kyotani, S., Nakanishi, N., Morisaki, T., Humbert, M., Simonneau, G., Sitbon, O., Soubrier, F., Coulet, F., Morrell, N.W., and Trembath, R.C. (2006). Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension. Hum Mutat 27, 121-32.
21. Machado, R.D., Pauciulo, M.W., Thomson, J.R., Lane, K.B., Morgan, N.V., Wheeler, L., Phillips, J.A., 3rd, Newman, J., Williams, D., Galie, N., Manes, A., McNeil, K., Yacoub, M., Mikhail, G., Rogers, P., Corris, P., Humbert, M., Donnai, D., Martensson, G., Tranebjaerg, L., Loyd, J.E., Trembath, R.C., and Nichols, W.C. (2001). BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. Am J Hum Genet 68, 92-102.
22. Machado, R.D., Rudarakanchana, N., Atkinson, C., Flanagan, J.A., Harrison, R., Morrell, N.W., and Trembath, R.C. (2003). Functional interaction between BMPR-II and Tctex-1, a light chain of Dynein, is isoform-specific and disrupted by mutations underlying primary pulmonary hypertension. Hum Mol Genet 12, 3277-86.
23. Mehra, A., Attisano, L., and Wrana, J.L. (2000). Characterization of SMAD phosphorylation and SMAD-receptor interaction. In Methods in Molecular Biology (P. H. Howe, ed., Vol. 142, pp. 67-78). Humana Press, Totowa, NJ.
24. Mineo, C., Gill, G.N., and Anderson, R.G. (1999). Regulated migration of epidermal growth factor receptor from caveolae. J Biol Chem 274, 30636-43.
25. Minshall, R.D., Sessa, W.C., Stan, R.V., Anderson, R.G., and Malik, A.B. (2003). Caveolin regulation of endothelial function. Am J Physiol Lung Cell Mol Physiol 285, L1179-83.
26. Miyazono, K. (1999). Signal transduction by bone morphogenetic protein receptors: functional roles of Smad proteins. Bone 25, 91-3.
27. Mukhopadhyay, S., Shah, M., Patel, K., and Sehgal, P.B. (2005). Monocrotaline pyrrole-induced megalocytosis of lung and breast epithelial cells: disruption of plasma membrane and Golgi dynamics and an enhanced unfolded protein response. Toxicol Appl Pharmacol 211, 209-20.
28. Nakao, A., Imamura, T., Souchelnytskyi, S., Kawabata, M., Ishisaki, A., Oeda, E., Tamaki, K., Hanai, J., Heldin, C.H., Miyazono, K., and ten Dijke, P. (1997). TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. Embo J 16, 5353-62.
29. Oh, S.P., Seki, T., Goss, K.A., Imamura, T., Yi, Y., Donahoe, P.K., Li, L., Miyazono, K., ten Dijke, P., Kim, S., and Li, E. (2000). Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci U S A 97, 2626-31.
30. Pepper, M.S., Vassalli, J.D., Orci, L., and Montesano, R. (1993). Biphasic effect of transforming growth factor-beta 1 on in vitro angiogenesis. Exp Cell Res 204, 356-63.
31. Pierreux, C.E., Nicolas, F.J., and Hill, C.S. (2000). Transforming growth factor beta-independent shuttling of Smad4 between the cytoplasm and nucleus. Mol Cell Biol 20, 9041-54.
32. Pollman, M.J., Naumovski, L., and Gibbons, G.H. (1999). Vascular cell apoptosis: cell type-specific modulation by transforming growth factor-beta1 in endothelial cells versus smooth muscle cells. Circulation 99, 2019-26.
33. Ramos, M., Lame, M.W., Segall, H.J., and Wilson, D.W. (2006). The BMP type II receptor is located in lipid rafts, including caveolae, of pulmonary endothelium in vivo and in vitro. Vascul Pharmacol 44, 50-9.
34. Ramos, M., Lame, M.W., Segall, H.J., and Wilson, D.W. (2007). Monocrotaline pyrrole induces Smad nuclear accumulation and altered signaling expression in human pulmonary arterial endothelial cells. Vascul Pharmacol 46, 439-48.
35. Razani, B., Engelman, J.A., Wang, X.B., Schubert, W., Zhang, X.L., Marks, C.B., Macaluso, F., Russell, R.G., Li, M., Pestell, R.G., Di Vizio, D., Hou, H., Jr., Kneitz, B., Lagaud, G., Christ, G.J., Edelmann, W., and Lisanti, M.P. (2001). Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 276, 38121-38.
36. Razani, B., Zhang, X.L., Bitzer, M., von Gersdorff, G., Bottinger, E.P., and Lisanti, M.P. (2001). Caveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta type I receptor. J Biol Chem 276, 6727-38.
37. Rodriguez-Pascual, F., Redondo-Horcajo, M., and Lamas, S. (2003). Functional cooperation between Smad proteins and activator protein-1 regulates transforming growth factor-beta-mediated induction of endothelin-1 expression. Circ Res 92, 1288-95.
38. Rosenzweig, B.L., Imamura, T., Okadome, T., Cox, G.N., Yamashita, H., ten Dijke, P., Heldin, C.H., and Miyazono, K. (1995). Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci U S A 92, 7632-6.
39. Schlegel, A., and Lisanti, M.P. (2001). The caveolin triad: caveolae biogenesis, cholesterol trafficking, and signal transduction. Cytokine Growth Factor Rev 12, 41-51.
40. Schultze, A.E., and Roth, R.A. (1998). Chronic pulmonary hypertension-the monocrotaline model and involvement of the hemostatic system. J Toxicol Environ Health B Crit Rev 1, 271-346.
41. Sotgia, F., Williams, T.M., Schubert, W., Medina, F., Minetti, C., Pestell, R.G., and Lisanti, M.P. (2006). Caveolin-1 deficiency (-/-) conveys premalignant alterations in mammary epithelia, with abnormal lumen formation, growth factor independence, and cell invasiveness. Am J Pathol 168, 292-309.
42. Thomas, H.C., Lame, M.W., Wilson, D.W., and Segall, H.J. (1996). Cell cycle alterations associated with covalent binding of monocrotaline pyrrole to pulmonary artery endothelial cell DNA. Toxicol Appl Pharmacol 141, 319-29.
43. Thomson, J.R., Machado, R.D., Pauciulo, M.W., Morgan, N.V., Humbert, M., Elliott, G.C., Ward, K., Yacoub, M., Mikhail, G., Rogers, P., Newman, J., Wheeler, L., Higenbottam, T., Gibbs, J.S., Egan, J., Crozier, A., Peacock, A., Allcock, R., Corris, P., Loyd, J.E., Trembath, R.C., and Nichols, W.C. (2000). Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family. J Med Genet 37, 741-5.
44. van den Driesche, S., Mummery, C.L., and Westermann, C.J. (2003). Hereditary hemorrhagic telangiectasia: an update on transforming growth factor beta signaling in vasculogenesis and angiogenesis. Cardiovasc Res 58, 20-31.
45. Williams, T.M., and Lisanti, M.P. (2005). Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol 288, C494-506.
46. Wilson, D.W., Segall, H.J., Pan, L.C., Lame, M.W., Estep, J.E., and Morin, D. (1992). Mechanisms and pathology of monocrotaline pulmonary toxicity. Crit Rev Toxicol 22, 307-25.
47. Wrana, J.L., and Attisano, L. (2000). The Smad pathway. Cytokine Growth Factor Rev 11, 5-13.
48. Xiao, Z., Watson, N., Rodriguez, C., and Lodish, H.F. (2001). Nucleocytoplasmic shuttling of Smad1 conferred by its nuclear localization and nuclear export signals. J Biol Chem 276, 39404-10.
49. Yang, X., Long, L., Southwood, M., Rudarakanchana, N., Upton, P.D., Jeffery, T., Atkinson, C., Chen, H., Trembath, R.C., and Morrell, N.W. (2005). Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension. Circ Res 96, 1053-63.
50. Zhao, Y.D., Courtman, D.W., Ng, D.S., Robb, M.J., Deng, Y.P., Trogadis, J., Han, R.N., and Stewart, D.J. (2006). Microvascular regeneration in established pulmonary hypertension by angiogenic gene transfer. Am J Respir Cell Mol Biol 35, 182-9.
51. Zhao, Y.Y., Liu, Y., Stan, R.V., Fan, L., Gu, Y., Dalton, N., Chu, P.H., Peterson, K., Ross, J., Jr., and Chien, K.R. (2002). Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice. Proc Natl Acad Sci U S A 99, 11375-80.